PTBP1 and pancreatic adenocarcinoma: A high expression of PTBP1 was correlated with a poor prognosis in patients with ESCA, KIRP, LIHC, LUAD, PAAD, or SARC, and related to better prognosis in patients with BLCA, ESCC, OV, READ, STAD, or THYM (Supplementary Figures S9A–9D).